What cautions should be considered when using beta-blockers in chronic ACS?

What cautions should be considered when using beta-blockers in chronic ACS?

• A. Only caution in patients with hypotension
• B. Bradycardia, cardiogenic shock, and symptoms of heart failure
• C. No cautions
• D. Increased risk of thrombocytopenia

Answer: (B)

Beta-blockers in chronic ACS are protective by lowering heart rate and myocardial workload, but they can worsen heart function if the heart isn’t pumping well. That’s why caution is needed in situations where reducing heart rate or contractility could drop cardiac output or blood pressure. The best answer highlights three key scenarios: bradycardia, which lowers cardiac output and can cause inadequate perfusion; cardiogenic shock, where the heart already isn’t delivering enough blood and further negative inotropic effects can be dangerous; and symptoms of heart failure, which signal that the heart is struggling to cope with reduced contractility and the drug could tip the balance toward decompensation. In practice, monitor heart rate, blood pressure, and signs of fluid overload; if bradycardia or hypotension occurs, or if there’s worsening heart failure, adjust or discontinue the beta-blocker. The other options don’t fit because they either miss a major risk (hypotension alone is insufficient to capture the full cautions), state there no cautions (incorrect), or mention an unrelated adverse effect (thrombocytopenia is not a primary caution with beta-blockers in this context).

Beta-blockers in chronic ACS are protective by lowering heart rate and myocardial workload, but they can worsen heart function if the heart isn’t pumping well. That’s why caution is needed in situations where reducing heart rate or contractility could drop cardiac output or blood pressure. The best answer highlights three key scenarios: bradycardia, which lowers cardiac output and can cause inadequate perfusion; cardiogenic shock, where the heart already isn’t delivering enough blood and further negative inotropic effects can be dangerous; and symptoms of heart failure, which signal that the heart is struggling to cope with reduced contractility and the drug could tip the balance toward decompensation. In practice, monitor heart rate, blood pressure, and signs of fluid overload; if bradycardia or hypotension occurs, or if there’s worsening heart failure, adjust or discontinue the beta-blocker. The other options don’t fit because they either miss a major risk (hypotension alone is insufficient to capture the full cautions), state there no cautions (incorrect), or mention an unrelated adverse effect (thrombocytopenia is not a primary caution with beta-blockers in this context).